USC Keck:  Epstein Breakthrough Alzheimer’s Research Fund

If you are interested in this opportunity, please contact Carole King at carole.king@med.usc.edu.

• LOI due September 4, 2025
• Budget up to $212,000 (no indirects)
• Project timeline is one year

Funds will be awarded to promote and support research to advance the development of new therapies and/or preventive measures for AD across the spectrum from pre-symptomatic to symptomatic disease.

Funding preference will be given to those projects that have the strongest potential to advance therapeutics in the next five years.